Celgene Corporation

Celgene Corporation is an integrated global biopharmaceutical company. The Company, together with its subsidiaries, is engaged in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases through solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation.
Company Growth (employees)
Type
Public
HQ
Summit, US
Founded
1986
Size (employees)
7,132 (est)
Celgene Corporation was founded in 1986 and is headquartered in Summit, US

Key People/Management at Celgene Corporation

Mark Alles

Mark Alles

Chief Executive Officer
Robert Hugin

Robert Hugin

Executive Chairman
Jacqualyn Fouse

Jacqualyn Fouse

President and Chief Operating Officer
Peter Kellogg

Peter Kellogg

Executive Vice President and Chief Financial Officer

Celgene Corporation Office Locations

Celgene Corporation has offices in Summit, Boudry and Singapore
Summit, US (HQ)
86 Morris Ave
Singapore, SG
200 Newton Rd
Boudry, CH
1 Route de Perreux

Celgene Corporation Financials and Metrics

Celgene Corporation Financials

Celgene Corporation's revenue was reported to be $11.2 b in FY, 2016
USD

Revenue (Q3, 2017)

3.3 b

Gross profit (Q3, 2017)

3.2 b

Gross profit margin (Q3, 2017), %

96%

Net income (Q3, 2017)

988 m

EBIT (Q3, 2017)

1.1 b

Market capitalization (13-Dec-2017)

88.2 b

Cash (30-Sep-2017)

5.5 b

EV

84.1 b
Celgene Corporation's current market capitalization is $88.2 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

6.5 b7.7 b9.3 b11.2 b

Revenue growth, %

18%21%21%

Cost of goods sold

340.4 m385.9 m420.1 m438 m

Gross profit

6.2 b7.3 b8.8 b10.8 b
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

2.3 b2.3 b2.5 b2.8 b3 b3 b3.3 b3.3 b

Cost of goods sold

100.8 m109.9 m105.9 m110.9 m107.7 m113 m111 m118 m

Gross profit

2.2 b2.2 b2.4 b2.6 b2.9 b2.8 b3.2 b3.2 b

Gross profit Margin, %

96%95%96%96%96%96%97%96%
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

3.2 b4.1 b4.9 b6.2 b

Inventories

340.4 m393.1 m443.4 m497.9 m

Current Assets

7.6 b9.7 b9.4 b10.9 b

PP&E

593.4 m642.6 m814.1 m929.8 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

2.4 b2.4 b3.2 b3.7 b4.4 b4.5 b6 b4.4 b5.1 b5.5 b5.3 b6.7 b5.5 b

Inventories

313.3 m347.8 m360 m372 m386.7 m414.3 m420.9 m470.6 m490.4 m507.9 m509 m533 m537 m

Current Assets

7.6 b6.9 b8.1 b8.8 b9.7 b9.9 b10.2 b8.4 b9.2 b9.6 b11.6 b13.1 b14.8 b

PP&E

592.3 m595.7 m605.1 m623.6 m649.7 m675.2 m702 m840 m854 m891.3 m958 m989 m1 b
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

1.4 b2 b1.6 b2 b

Accounts Receivable

(101.4 m)(166.3 m)(304.7 m)(222.4 m)

Inventories

(89.7 m)(56.5 m)(50.6 m)(55.3 m)

Cash From Operating Activities

2.2 b2.8 b2.5 b4 b
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

1.2 b279.7 m877.5 m1.4 b718.9 m1.1 b1 b800.7 m1.4 b1.6 b941 m2 b3 b

Depreciation and Amortization

71.8 m25.5 m52.1 m78.1 m28.1 m57.8 m86.6 m29.2 m58.5 m89.6 m32 m66 m100 m

Accounts Receivable

(138.7 m)(9.8 m)(61.8 m)(46 m)(59.5 m)(140.9 m)(145.8 m)23.1 m(80.7 m)(143.8 m)17 m(75 m)(139 m)

Inventories

(62.6 m)(7 m)(19.1 m)(33.6 m)7.3 m(19.2 m)(27.1 m)(25.6 m)(45.2 m)(62.3 m)(10 m)(32 m)(37 m)
USDY, 2017

EV/EBIT

77.5 x

EV/CFO

23.6 x

EV/FCF

24.9 x

Revenue/Employee

460.9 k

Financial Leverage

3.2 x
Show all financial metrics

Celgene Corporation Operating Metrics

FY, 2016

Active Clinical Studies

52
Show all operating metrics

Celgene Corporation Market Value History

Celgene Corporation Median Salaries

Source: 55 public H-1B filings from Celgene Corporation

Celgene Corporation's Web-traffic and Trends

Celgene Corporation Online and Social Media Presence

Celgene Corporation Company Life and Culture

You may also be interested in